aclacinomycin has been researched along with peplomycin in 2 studies
| Studies (aclacinomycin) | Trials (aclacinomycin) | Recent Studies (post-2010) (aclacinomycin) | Studies (peplomycin) | Trials (peplomycin) | Recent Studies (post-2010) (peplomycin) |
|---|---|---|---|---|---|
| 168 | 8 | 21 | 533 | 51 | 13 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Umezawa, H | 1 |
| Kanamori, T; Kimoto, T; Namba, M; Nobuhara, M; Tanaka, H; Yamamoto, S | 1 |
2 other study(ies) available for aclacinomycin and peplomycin
| Article | Year |
|---|---|
Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part I - Antitumor antibiotics and their derivatives.
Topics: Aclarubicin; Adjuvants, Immunologic; Animals; Antibiotics, Antineoplastic; Bleomycin; Daunorubicin; Doxorubicin; Humans; Leukemia L1210; Lung; Lung Neoplasms; Mice; Molecular Weight; Naphthacenes; Peplomycin; Structure-Activity Relationship | 1982 |
[Potentiation of the cytotoxic effects of various anticancer drugs by interferon on human neoplastic cells (HeLa) in culture].
Topics: Aclarubicin; Antineoplastic Agents; Bleomycin; Cell Division; Cisplatin; Doxorubicin; Drug Synergism; Fluorouracil; HeLa Cells; Humans; Interferons; Naphthacenes; Peplomycin | 1983 |